Autism Biomarkers Consortium for Clinical Trials (ABC-CT)

Keywords: ASD, Eye tracking, EEG, consortium, Biomarkers

What is being studied?

The goal of this study is to develop reliable and objective measurements of social function and communication in people with autism spectrum disorder (ASD).  Children will be monitored over a six-month period using EEG to measure brain function, eye tracking technology to measure visual attention, behavioral assessments and automated recording techniques to assess behavior and speech.  These measures aim to validate a set of tools that will enable clinicians to objectively measure and predict how children with ASD will respond to treatment.

Who can participate?

School-aged children (4-11 years) with ASD and typical development (TD) are invited to participate.

What is being studied and what does the study involve?

The goal of this study is to develop reliable and objective measurements of social function and communication in people with autism spectrum disorder (ASD).  Across three time points over a six-month period, participants’ social function and communication will be monitored using EEG to measure brain function, eye tracking technology to measure visual attention, behavioral assessments and automated recording techniques to assess behavior and speech.  These measures aim to validate a set of tools that will enable clinicians to objectively measure and predict how children with ASD will respond to treatment.

Whom should I contact to get involved?

Lead Research Coordinator: Elizabeth Baker (310) 825-0180 or by email at

Comments are closed